← Open Payments lookup

AKILA BOOZER: Open Payments

NPI 1316594724 · GREENWOOD, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,478 in 138 payments from 14 companies in 2025. Trend: 2023 $2,412 · 2024 $1,701 · 2025 $2,478

Food & beverage: $2,478
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.22$471
Neurocrine BioSciences, Inc.15$382
ABBVIE INC.24$265
E.R. Squibb & Sons, L.L.C.14$255
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)12$218
Alkermes, Inc.9$198
Teva Pharmaceuticals USA, Inc.14$187
Janssen Pharmaceuticals, Inc10$146
Supernus Pharmaceuticals, Inc.5$91
Vanda Pharmaceuticals Inc.4$71

Products named: INGREZZA, COBENFY, VRAYLAR, ABILIFY MAINTENA, CAPLYTA, REXULTI, INVEGA SUSTENNA, UZEDY.

Industry payments across SC — which companies pay providers there.